ReviewRSC advances2024
Insights into micro-and nano-zero valent iron materials: synthesis methods and multifaceted applications.
Review in RSC advances, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed.
- Kinetic modelling and equilibrium behaviour of methylene blue adsorption in sequentially modified PVDF/NC/TiORSC advances · 2026Article
- Fabrication and performance evaluation of nZVI integrated PVDF nanocomposite membranes for the remediation of lead contaminated wastewater.Discover nano · 2026Article
- Enhanced hydrophilic properties and performance evaluation of PVDF-TiORSC advances · 2026Article
- Green Synthesis of Biochar-Supported Nanoscale Zero-Valent Iron Using Tea Polyphenol for Efficient Cadmium Immobilization in Soil.Nanomaterials (Basel, Switzerland) · 2025Article
- Kinetic and thermodynamic investigation of the removal of alizarin red dye using silica-supported nanoscale zero-valent iron particles.Scientific reports · 2025Article
- Application of Fourier Transform Infrared (FTIR) Spectroscopy in Characterization of Green Synthesized Nanoparticles.Molecules (Basel, Switzerland) · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The growing threat of environmental pollution to global environmental health necessitates a focus on the search for sustainable wastewater remediation materials coupled with innovative remediation strategies. Nano and micro zero-valent iron materials have attracted substantial researchers' attention due to their distinct physiochemical properties. This review article delves into novel micro- and nano-zero valent iron (ZVI) materials, analysing their synthesis methods, and exploring their multifaceted potential as a powerful tool for environmental remediation. This analysis contributes to the ongoing search of effective solutions for environmental remediation. Synthesis techniques are analysed based on their efficacy, scalability, and environmental impact, providing insights into existing methodologies, current challenges, and future directions for optimisation. Factors influencing ZVI materials' physicochemical properties and multifunctional engineering applications, including their role in wastewater and soil remediation, are highlighted. Environmental concerns, pros and cons, and the potential industrial applications of these materials are also discussed, accenting the importance of understanding the synthesis methods, materials' applications and their impacts on humans and the environment. The review is designed to provide insights into nano-and micro-ZVI materials, and their potential engineering applications, as well as guide researchers in the choice of ZVI materials' synthesis methods from a variety of nanoparticle synthesis strategies fostering nexus between these methods and industrial applications.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.